BPG is committed to discovery and dissemination of knowledge
Systematic Reviews
Copyright: ©Author(s) 2026.
World J Methodol. Jun 20, 2026; 16(2): 114322
Published online Jun 20, 2026. doi: 10.5662/wjm.v16.i2.114322
Table 2 Summary of representative studies reporting long-term stroke and vascular outcomes in women with a history of hypertensive disorders of pregnancy
Ref.
Design/setting
Exposure/comparison
Sample (exposed/ref)
Follow-up (years)
Stroke outcome(s)
Effect (95%CI)
Notes
Verburgt et al[19], 2025Case-control, young women with ischemic stroke vs population controlsAny APO; HDP (PE/PIH) vs none358 stroke/714 refUp to prior pregnanciesIschemic strokePE OR: 4.0 (2.4-6.8); HDP OR: 2.0 (1.4-2.7); SGA OR: 2.8 (2.0-3.9); Preterm OR: 2.7 (1.9-4.0)HDP strongest with large-artery disease; suggests atherosclerotic mechanism in some cryptogenic strokes
Crump et al[20], 2025Nationwide cohort, SwedenAPOs (PTB, SGA, PE, other HTN, GDM) vs none35824 stroke/2201393 totalUp to 46All strokePE aHR: 1.36 (1.31-1.41); other HTN 1.82 (1.67-1.98); GDM 1.86 (1.69-2.04); PTB 1.40 (1.36-1.45); SGA 1.26 (1.22-1.29)Risks persisted 30-46 years; partly explained by shared familial factors
Hung et al[21], 2022Nationwide cohort, TaiwanHDP subtypes vs non-HDP13617 HDP/54468 ref≤ 17Any, ischemic, hemorrhagicAny aHR: 1.71 (1.46-2.00); Isch aHR: 1.60 (1.35-1.89); Hem aHR: 2.98 (2.13-4.18)Isch peak 1-3 years (aHR: 2.14); Hem peak 10-15 years (aHR: 4.64); highest with CH superimposed PE (aHR: 3.86)
Auger et al[36], 2020Provincial cohort, CanadaVery/moderate PTB vs term; mediation by maternal vascular disorders (including PE)1199364Approximately 10-20Ischemic stroke hospitalizationIncidence higher with PTB. For 95%CI PE explained 8.3% (very PTB) and 11.0% (moderate PTB) of PTB-stroke associationSpecific stroke HRs by PTB reported; PE key mediator of PTB → stroke/CVD
Garovic et al[23], 2020Historical cohort, Olmsted County (United States)Prior HDP vs matched referents571 HDP/1142 refMedian 36Any strokeHR: 2.27 (1.37-3.76)HDP also increase CAD, CKD, arrhythmia; robust to adjustments
Arnott et al[24], 2020National registry, AustraliaHDP (early-onset < 34 weeks) × smoking vs no HDP528106 (first births)10 (risk estimate)Composite CVD (including ischemic stroke)EO-HDP, non-smokers HR: 4.90 (3.00-7.80); EO-HDP + smoking HR: 23.5 (13.5-40.5)Stroke included in composite; strong interaction with smoking
Gastrich et al[25], 2020Matched cohort, United StatesHistory of PE vs matched controls6360 PE/325347 refUp to several yearsHospitalized strokeHR: 1.81 (0.75-4.37) (NS)MI and CV death increase; stroke directionally increase but underpowered
Kuo et al[26], 2018Nationwide cohort, TaiwanPE/eclampsia vs age-matched controls1295 cases/5180 refApproximately 10Cerebrovascular disease (stroke)Eclampsia HR: 10.71 (3.45-33.24); PE HR: 3.47 (1.46-8.23)Hemorrhagic stroke: Eclampsia HR: 19.74; PE NS
Lobitz et al[27], 2024National admin cohort, AustraliaCaesarean vs vaginal; adjusted including HDP/DM14179299≤ 365 days PPStroke readmissionHR: 1.40 (1.26-1.56)Increase 180-365 days (HR: 1.94)
Lin et al[29], 2016Nationwide cohort, TaiwanPIH vs non-PIH28346 PIH/113384 refApproximately 10Intracranial hemorrhageaHR: 2.81 (1.58-4.99)Hemorrhagic risk increasing strongly
Nelander et al[30], 2016Cohort, Sweden (≥ 65 years)Any HDP vs none3232To late lifeAny strokeHR: 1.36 (borderline)Attenuated at oldest ages
Akhter et al[35], 2014Vascular imaging cohort, NorwaySevere PE vs normotensive42 PE/44 ref9 years (range 1-13)Vascular surrogate (carotid IMT/plaques)Intima 013 ± 0.02 mm vs 0.08 ± 0.01 mm (+63%); I/M ratio 0.27 ± 0.07 vs 0.15 ± 0.03 (+80%); IMT 063 ± 0.12 mm vs 0.61 ± 0.12 mm (+3%); media -7%Increased carotid intimal thickening and arterial remodeling consistent with early subclinical atherosclerosis after severe PE


Write to the Help Desk